Pubblicazioni

SPLEEN ENLARGEMENT IS A RISK FACTOR FOR THROMBOSIS IN ESSENTIAL THROMBOCYTHEMIA: EVALUATION ON 1097 PATIENTS AND VALIDATION ON 792 PATIENTS

2015 - HAEMATOLOGICA

Andriani, A; Latagliata, R; Anaclerico, B; Spadea, A; Rago, A; Di Veroli, A; Spirito, F; Porrini, R; De Muro, M; Leonetti, Sc; Villiva, N; De Gregoris, C; Montefusco, E; Polverelli, N; Santoro, Cristina; Breccia, M; Cimino, Giuseppe; Majolino, I; Mazzucconi, Maria Gabriella; Vianelli, N; Alimena, G; Montanaro, M; Palandri, F.

OUTCOMES OF 65 PREGNANCIES IN 34 WOMEN WITH 5 DIFFERENT FORMS OF INHERITED PLATELET FUNCTION DISORDERS ENROLLED IN A RETROSPECTIVE AND MULTICENTRIC STUDY

2015 - HAEMATOLOGICA

Noris, P; Civaschi, E; Klersy, C; Melazzini, F; Pujol Moix, N; Santoro, Cristina; Cattaneo, M; Lavenu Bombled, C; Bury, L; Minuz, P; Nurden, P; Cid Haro, Ar; Cuker, A; Latger Cannard, V; Favier, R; Nichele, I; Balduini, Cl

BLEEDING RISK OF SURGERY IN PATIENTS WITH INHERITED PLATELET FUNCTION DISORDERS (IPFD): OUTCOME OF 389 SURGERIES IN 205 PATIENTS

2015 - HAEMATOLOGICA

Gresele, P; Noris, P; Orsini, S; Heller, P; Santoro, Cristina; Bury, L; Kadir, R; Mezzano, D; Falcinelli, E; Butta, N; Cid, Ar; Pozo, Jr; Miyazaki, K; Fabris, F; Fouassier, M; Flaujac, C; Ozdemir, Gn; Otomewo, O; Melazzini, F; Favier, R; Cattaneo, M; Bussel, J; De Maistre, E; Henskens, Y; De Candia, E; Bernejo, N; Schlegel, N.

HOW DIAGNOSTIC AND THERAPEUTIC APPROACHE CHANGED IN THE LAST DECADES IN THE PHILADELPHIA NEGATIVE MPN PATIENTS OF THE REGISTRO ITALIANO TROMBOCITEMIE (RIT)

2015 - HAEMATOLOGICA

Gugliotta, L; Iurio, A; Gugliotta, G; Tieghi, A; Candoni, A; Lunghi, M; Dragani, A; Antonioli, E; Scalzulli, Pr; Martinelli, V; Martino, B; Randi, Ml; Ricco, A; Appolloni, V; Maschio, N; Palmieri, R; Langella, M; Santoro, Cristina; Rago, A; Ragionieri, R; Codeluppi, K; Cacciola, E; Cacciola, R; Mastrullo, L; Esposito, Mr; Caocci, G; Lanza, F; Rupoli, S; Pierri, I; Porretto, F; Melpignano, A; Crugnola, M; Di Ianni, M; Plebani, S; Molinari, E; Spinosa, G; Santoro, M; Villani, O; Ricciotti, M; Musolino, C; Usala, E; Falzetti, F; De Biasi, E; Santoro, U; Federici, A; Vianelli, N; Mazzucconi, Maria Gabriella; Specchia, G.

ROLE OF TREATMENT ON THE DEVELOPMENT OF SECONDARY MALIGNANCIES IN PATIENTS WITH ESSENTIAL THROMBOCYTEMIA

2015 - HAEMATOLOGICA

Santoro, Cristina; Sperduti, I; Di Giandomenico, J; De Muro, M; Villiva, N; Di Veroli, A; Montanaro, M; Latagliata, R; Anaclerico, B; Giuseppe, A; Breccia, M; Cedrone, M; Cimino, Giuseppe; Felici, S; Crescenzi, Sl; Majolino, I; Montefusco, E; Montanaro, G; Porrini, R; Rago, A; Spadea, A; Spirito, F; Alimena, Giuliana; Andriani, A; Foa, Roberto; Mazzucconi, Maria Gabriella

HIGH DOSE SEQUENTIALCHEMOTHERAPY WITH RITUXIMAB AND ASCT AS FIRST LINE THERAPY IN ADULT MCL PATIENTS: CLINICAL AND MOLECULARRESPONSE OF THE MCL0208 TRIAL, A FIL STUDY

2015 - HAEMATOLOGICA20th Congress of European-Hematology-Association

Cortelazzo, S; Martelli, Maurizio; Ladetto, M; Ferrero, S; Ciccone, G; Evangelista, A; Mian, M; DI ROCCO, Alice; Chiappella, A; Rossi, G; Re, A; Zinzani, Pl; Balzarotti, M; Cavallo, F; Rusconi, C; Gotti, M; Arcaini, L; Gobbi, M; Gomes, M; Molinari, A; Liberati, Am; Michieli, M; Latte, G; Cabras, Mg; Novero, D; Paulli, M; Zamo, A; Chilosi, M; Federico, M; Vitolo, U.

THE IELSG-32 TRIAL: RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE AND HIGH-DOSE CYTARABINE WITH OR WITHOUT THIOTEPA, AND WITH OR WITHOUT RITUXIMAB, FOLLOWED BY BRAIN IRRADIATION VS HIGH-DOSE CHEMOTHERAPY SUPPORTED BY AUTOLOGOUS STEM CELLS TRANSPLANTATION FOR IMMUNOCOMPETENT PATIENTS WITH NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA

2015 - HAEMATOLOGICA45th Congress of the Italian-Society-of-Hematology

Ferreri, Ajm; Cwynarski, K; Pulczynski, E; Ponzoni, M; Politi, Ls; Ambrosetti, A; Vitolo, U; Ilariucci, F; Balzarotti, M; Fabbri, A; Tucci, A; Pisani, F; Levis, A; Cabras, Mg; D'Arco, M; Zaccaria, A; Angrilli, F; Guarini, Anna; Imola, M; Martelli, Maurizio; Cervetti, J; Zaja, F; Pinto, A; Liberati, M; Morra, E; Cortellazzo, Sf; Bassan, R; Foppoli, M; Citterio, G; Sassone, M; Scarfo, L; Cavalli, F; Finke, J; Reni, M; Zucca, E; Illerhaus, G.

The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study

2015 - HAEMATOLOGICA

Rossi, D.; Bruscaggin, A.; La Cava, P.; Galimberti, S.; Ciabatti, E.; Luminari, S.; Rigacci, L.; Tucci, A.; Pulsoni, A.; Bertoldero, G.; Vallisa, D.; Rusconi, C.; Spina, M.; Arcaini, L.; Angrilli, F.; Stelitano, C.; Merli, F.; Gaidano, G.; Federico, M.; Palumbo, G. A.

Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood

2015 - HAEMATOLOGICA

Aalbers, A. M.; Van Den Heuvel-Eibrink, M. M.; Baumann, I.; Dworzak, M.; Hasle, H.; Locatelli, F.; De Moerloose, B.; Schmugge, M.; Mejstrikova, E.; Novakova, M.; Zecca, M.; Michel Zwaan, C.; Te Marvelde, J. G.; Langerak, A. W.; Van Dongen, J. J.; Pieters, R.; Niemeyer, C. M.; Van Der Velden, V. H.

Clinical features and outcome of SIL/TAL1-positive t-cell acute lymphoblastic leukemia in children and adolescents: A 10-year experience of the AIEOP group

2015 - HAEMATOLOGICA

D'AngiÃ², M; Valsecchi, Mg; Testi, Anna Maria; Conter, V; Nunes, Vittorio; Parasole, R; Colombini, A; Santoro, N; Varotto, S; Caniglia, M; Silvestri, D; Consarino, C; Levati, L; Magrin, E; Locatelli, F; Basso, G; Foa, Roberto; Biondi, A; Cazzaniga, G.

Impact of maintenance therapy on subsequent treatment in patients with newly diagnosed multiple myeloma: use of "progression-free survival 2" as a clinical trial end-point.

2015 - HAEMATOLOGICA

Dimopoulos, Ma; Petrucci, Mt; Foa, Roberto; Catalano, J; Kropff, M; Terpos, E; Zhang, J; Grote, L; Jacques, C; Palumbo, A.

Long-term outcome of a phase 2 trial with nilotinib 400 mg twice daily in first-line treatment of chronic myeloid leukemia

2015 - HAEMATOLOGICA

Gugliotta, Gabriele; Castagnetti, Fausto; Breccia, Massimo; Levato, Luciano; DâAdda, Mariella; Stagno, Fabio; Tiribelli, Mario; Salvucci, Marzia; Fava, Carmen; Martino, Bruno; Cedrone, Michele; Bocchia, Monica; Trabacchi, Elena; Cavazzin, Francesco; Usala, Emilio; Rossi, Antonella Russo; Bochicchio, Maria Teresa; Soverini, Simona; Alimena, Giuliana; Cavo, Michele; Pane, Fabrizio; Martinelli, Giovanni; Saglio, Giuseppe; Baccarani, Michele; Rosti, Gianantonio

Aging and blood disorders: New perspectives, new challenges

2015 - HAEMATOLOGICA

Bron, D; Ades, L; Fulop, T; Goede, V; Stauder, R; Elderly Task Force in Hematology, EHA SWG; Foa, Roberto

PULMONARY INFECTIONS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA RECEIVING AZACITIDINE TREATMENT

2015 - HAEMATOLOGICA

De Angelis, F; Latagliata, R; De Luca, Ml; Carmosino, I; Vozella, F; Petrucci, L; Colafigli, G; Mancini, M; Morano, Sg; Brunetti, G; Breccia, M; Alimena, G; Girmenia, C

PREDICTORS OF DEEP MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONTLINE WITH IMATINIB MESYLATE: AN ANALYSIS BY THE GIMEMA CML WP

2015 - HAEMATOLOGICA

Castagnetti, F; Gugliotta, G; Breccia, M; Specchia, G; Binotto, G; Abruzzese, E; Iurlo, A; Vigneri, P; Cavazzini, F; Intermesoli, T; Ferrero, D; Martino, B; Leoni, P; Bocchia, M; Rege-Cambrin, G; Gherlinzoni, F; Bochicchio, Mt; Soverini, S; Alimena, G; Pane, F; Saglio, G; Cavo, M; Martinelli, G; Baccarani, M; Rosti, G

DEEP MOLECULAR RESPONSE TO NILOTINIB AS FIRST-LINE TREATMENT OF BCR-ABL plus CML

2015 - HAEMATOLOGICA

Castagnetti, F; Gugliotta, G; Breccia, M; Rossi, G; Stagno, F; Turri, D; Pregno, P; Tiribelli, M; Trabacchi, E; Carella, Am; Isidori, A; Pierri, I; Salvucci, M; Specchia, G; Levato, L; Avanzini, P; Bochicchio, Mt; Soverini, S; Alimena, G; Cavo, M; Martinelli, G; Pane, F; Saglio, G; Baccarani, M; Rosti, G

A POPULATION-BASED STUDY OF MYELODYSPLASTIC SYNDROMES PATIENTS IN THE LAZIO REGION (ITALY), MISCODING IN MEDICAL CLAIMS AND 11-YEAR MORTALITY FOLLOW-UP: THE GRUPPO ROMANO-LAZIALE MIELODISPLASIE EXPERIENCE OF RETROSPECTIVE MULTICENTRIC REGISTRY

2015 - HAEMATOLOGICA

Mayer, F; Fenu, S; Agabiti, N; Buccisano, F; Latagliata, R; Ricci, R; Spiriti, Maa; Breccia, M; Cimino, G; Fianchi, L; Gumenyuk, S; Mancini, S; Maurillo, L; Nobile, C; Niscola, P; Piccioni, Al; Tafuri, A; Trape, G; Voso, Mt; Davoli, M; Zini, G

UNFAVORABLE KARYOTYPE AND MOLECULAR NEGATIVITY SIGNIFICANTLY INFLUENCE THE INFECTIOUS RISK IN MYELOFIBROSIS: EVALUATION ON 426 PATIENTS

2015 - HAEMATOLOGICA

Polverelli, N; Breccia, M; Benevolo, G; Latagliata, R; Catani, L; Perricone, M; Sollazzo, D; Colafigli, G; Nicolosi, M; Campana, A; Vitolo, U; Alimena, G; Martinelli, G; Cavo, M; Vianelli, N; Palandri, F

DASATINIB FIRST-LINE: UPDATE DI UNA ESPERIENZA "REAL-LIFE" ITALIANA

2015 - HAEMATOLOGICA

Breccia, M; Annunziata, M; Nardiello, I; Maggi, A; Sgherza, N; Russo-Rossi, A; Pregno, P; Castagnetti, F; Iurlo, A; Latagliata, R; Cedrone, M; Di Renzo, N; Sora, F; Rege-Cambrin, G; Caocci, G; Scortechini, Ar; Greco, G; Franceschini, L; Sica, S; Bocchia, M; Crugnola, M; Orlandi, E; Stagno, F; Luciano, L; Abruzzese, E; Rosti, G; Specchia, G; Guarini, A; Saglio, G; Alimena, G

INFECTIOUS RISK IN MYELOFIBROSIS: EVALUATION ON 426 PATIENTS

2015 - HAEMATOLOGICA

Polverelli, N; Breccia, M; Benevolo, G; Latagliata, R; Catani, L; Nicolosi, M; Perricone, M; Sollazzo, D; Romano, M; Colafigli, G; Forte, D; Campana, A; Testoni, N; Vitolo, U; Alimena, G; Martinelli, G; Cavo, M; Vianelli, N; Palandri, F

VERY ELDERLY CP-CML PATIENTS TREATED WITH IMATINIB FRONTLINE: HAVE CONCOMITANT THERAPIES AN IMPACT ON OUTCOME AND TOXICITY?

2015 - HAEMATOLOGICA

Iurlo, A; Latagliata, R; Bucelli, C; Ferrero, D; Castagnetti, F; Breccia, M; Abruzzese, E; Fava, C; Annunziata, M; Stagno, F; Vigneri, P; Tiribelli, M; Cavazzini, F; Binotto, G; Mansueto, G; Gozzini, A; Russo, S; Falzetti, F; Montefusco, E; Gugliotta, G; Cattaneo, D; Djade, Cd; Cedrone, M; Rossi, Ar; Avanzini, P; Pregno, P; Mauro, E; Endri, M; Spadea, A; Celesti, F; Giglio, G; Isidori, A; Crugnola, M; Calistri, E; Sora, F; Sica, S; Storti, S; D'Addosio, A; Rege-Cambrin, G; Luciano, L; Saglio, G; Rosti, G; Alimena, G; Nobili, A; Cortelezzi, A

APPLICATION OF CARDIOVASCULAR RISK ASSESSMENT IN CHRONIC PHASE CML PATIENTS TREATED WITH NILOTINIB ALLOWS IDENTIFICATION OF SUBJECTS AT HIGH RISK OF EVENTS

2015 - HAEMATOLOGICA

Breccia, M; Colafigli, G; Quattrocchi, L; Saracino, R; Alimena, G

ACCURACY OF PHYSICIAN ASSESSMENT OF TREATMENT PREFERENCES AND HEALTH STATUS IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES

2015 - HAEMATOLOGICA

Caocci, G; Voso, Mt; Angelucci, E; Stauder, R; Cottone, F; Abel, G; Nguyen, Ktt; Platzbecker, U; Beyne-Rauzy, O; Gaidano, G; Invernizzi, R; Molica, S; Criscuolo, M; Breccia, M; Lubbert, M; Sanpaolo, G; Buccisano, F; Ricco, A; Palumbo, G; Niscola, P; Zhang, H; Fenu, S; La Nasa, G; Mandelli, F; Efficace, F

PULMONARY INFECTIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES RECEIVING AZACYTIDINE TREATMENT

2015 - HAEMATOLOGICA

Latagliata, R; De Angelis, F; De Luca, Ml; Carmosino, I; Vozella, F; Montagna, C; Romano, A; Petrucci, L; Salaroli, A; Molica, M; Colafigli, G; Mancini, M; Breccia, M; Alimena, G; Girmenia, C

PROGNOSTIC FACTORS ASSOCIATED TO ACHIEVEMENT OF STABLE MR4.5 IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB

2015 - HAEMATOLOGICA

Breccia, M; Colafigli, G; Molica, M; De Angelis, F; Quattrocchi, L; Latagliata, R; Mancini, M; Diverio, D; Alimena, G